- Home
- / JW Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
JW Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩26.7 K
2024-10-29
Market Capitalization
₩620.2 B
2024-10-29
Revenue
₩775.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 537.2B | 511.3B | 547.3B | 606.6B | 684.4B | 748.5B | 719.4B | 775.3B |
| Cost of goods sold | 304.8B | 305.9B | 322.5B | 326.0B | 348.2B | 355.0B | 376.8B | 397.2B |
| Gross profit | 240.9B | 209.1B | 228.2B | 284.1B | 339.8B | 398.9B | 347.8B | 384.0B |
| Gross profit margin, % | 44.8% | 40.9% | 41.7% | 46.8% | 49.7% | 53.3% | 48.4% | 49.5% |
| Operating expense total | 193.8B | 206.5B | 207.8B | 233.3B | 256.4B | 270.7B | 241.0B | 264.9B |
| Depreciation and amortization | 18.1B | 18.1B | 18.4B | 16.1B | 21.7B | 22.6B | 20.5B | 18.7B |
| EBITDA | 46.9B | 2.3B | 18.5B | 49.6B | 82.1B | 128.9B | 108.2B | 121.4B |
| EBITDA margin, % | 8.7% | 0.4% | 3.4% | 8.2% | 12.0% | 17.2% | 15.0% | 15.7% |
| EBIT | 18.8B | (24.0B) | (4.0B) | 29.7B | 46.8B | 60.5B | 85.7B | 89.2B |
| EBIT margin, % | 3.5% | -4.7% | -0.7% | 4.9% | 6.8% | 8.1% | 11.9% | 11.5% |
| Interest income | 9.2M | 128.0M | 628.7M | 1.7B | 5.3B | 5.9B | 4.9B | 3.2B |
| Interest expense | 8.7B | 11.3B | 7.6B | 7.3B | 9.4B | 12.6B | 10.0B | 4.4B |
| Pre tax profit | 10.2B | (34.3B) | (13.2B) | 20.5B | 45.4B | 54.8B | 82.4B | 88.8B |
| Income tax expense | 2.2B | (9.1B) | 2.1B | 22.0B | 15.5B | 16.4B | 17.4B | 27.3B |
| Net Income | 8.1B | (25.3B) | (15.3B) | (1.4B) | 29.9B | 38.4B | 65.0B | 61.5B |